BTIG Reiterates Buy Rating on Vericel Corporation (VCEL)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Wall St futures tick higher as oil retreats ahead of inflation data
- Oil falls on weaker demand outlook and higher US stocks
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Birkenstock surges on revenue beat, higher full-year outlook
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Vericel Corporation (VCEL) PT Raised to $60 at TD Cowen
August 26, 2024 12:30 PM EDTTD Cowen analyst Joshua Jennings raised the price target on Vericel Corporation (NASDAQ: VCEL) to $60.00 (from $55.00) while maintaining a Buy rating.
The analyst comments "VCEL announced that the FDA approved its supplemental BLA filing for MACI Arthro. Management had been guiding to a 3Q approval, so we are encouraged to see an FDA decision within the expected timeline. This approval represents an expansion of the current MACI offering to include... More
Vericel (VCEL) Announces FDA Approval and Commercial Availability of MACI Arthro
August 26, 2024 7:48 AM EDTVericel Corporation (NASDAQ: VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) expanding the MACI® (autologous cultured chondrocytes on porcine collagen membrane) label to include arthroscopic delivery of MACI to repair symptomatic single or multiple full-thickness cartilage defects of the knee up to 4 cm2 in size. MACI ArthroTM provides a less invasive technique compared to the current approach, allowing surgeons to evaluate and... More
